Industry Perspectives

91. What's Wrong With The Medtech R&D Department? 11/22/2022

    Executives, staff members, and investors of medical device companies commonly ask, “What’s wrong with the R&D department? What’s taking so long?" This article discusses five common culprits and the common thread solution that could solve all of them.

92. Wearable Electro-Patches: 4 Development Considerations 10/26/2022

    When developing wearable sensor patches capable of providing medical-grade monitoring, we must begin by appreciating that creating a fully functional system involves some essential building blocks, all of which must work together.

93. Autonomous Supply Chain Planning Is Within Reach 10/19/2022

    In a fast-paced industry constantly innovating — from personalized medicine to health wearables — life sciences companies must be prepared to adopt transformative technologies that can help them meet the demands of the future of medicine. Autonomous supply chain planning is not science fiction; it's here, and it's now. Building a practical road map will help.

94. You Have A Medical Device Proof Of Concept. Now What? 10/5/2022

    No matter what the medical device in development, the first major milestone is usually proof of concept. How do you go from a build-of-one device to something you can manufacture reliably and at scale? This article shares key considerations in engineering and design, quality systems, and more.

95. Human Factors Methodology In Medical Device Design For FDA Approval 10/3/2022

    Human factors engineering processes are a critical component that should be considered throughout the full medical device development continuum rather than as a final requirement to check off at the end. This article shares tips for methodologies to enable FDA approval of your device.

96. 3 Steps For A Smarter Medtech Supply Chain 9/21/2022

    Our medtech industry has a huge opportunity to make our supply chains “smarter" by making the most of digital technologies and data. But we need to work in an agile manner to adopt and scale technology. This article shares three main steps to take.

97. Lab-On-Chip Devices: Materials Considerations 9/15/2022

    Material selection and testing can often be one of the critical challenges to developing microfluidic devices for the healthcare and life sciences markets. This article shares recommendations related to determining which physical properties are needed, potentially suitable materials, processing techniques, and analytical techniques.

98. Biosynthetic Cellulose For Wound Healing – Your Questions Answered 6/1/2022

    Biosynthetic cellulose is a nature-inspired material that can be used to reduce pain and risk of infection for wounds such as burns. Dr. Uwe Beekmann, head of R&D for JeNaCell, discusses the story behind biosynthetic cellulose and what developments the future holds.

99. How Does Pursuing ESG Measures Give My Medtech A Competitive Edge? 5/27/2022

    Amid continuing focus on environmental, social, and governance (ESG) priorities among investors across every industry, medtech companies need to begin revisiting business models and developing new sustainability strategies for competitive edge as well as regulatory compliance.

100. Medical Device 3D Printing & Prototyping: Lessons Learned 4/27/2022

     Nearly a decade ago, this author came up with the concept for a new medical device. In bringing that concept to fruition, he looked into 3D printing and prototyping. This article describes his process and lessons learned from the experience. Fortunately, 3D printing is now more accessible and easier to accomplish for medical device developers, so hopefully your challenges will be less of an obstacle.